About FireGate Biotech Inc. FireGate Biotech Inc. is a translational immunology startup pioneering next-generation host-directed therapeutics. The company’s FireGate Triplet platform integrates CCR5/CCR2 blockade, PD-L1 pathway modulation, and neuro-immune repair to advance therapies across infectious disease, oncology, and neuroinflammation. FireGate operates under an open-science model that emphasizes transparency, scientific rigor, and global access to innovation. Learn more at https://firegatebiotech.com .